MedPath

Post marketing clinical trial of TJ-54

Phase 4
Conditions
europsychiatric symptoms of Parkinson`s disease
Registration Number
JPRN-jRCT1080220598
Lead Sponsor
Tsumura & Co.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
76
Inclusion Criteria

1.Patients with NPI subscale score of 4 points or greater on more than one subscale 4 weeks prior to and at the start of treatment
2.Patients with MMSE (Mini-Mental State Examination) score of 24 points or greater 4 weeks prior to and at the start of treatment

Exclusion Criteria

1.Patients who are diagnosed with dementia based on DSM-IV criteria [Diagnostics and Statistical Manual of Mental Disorders, 4th Edition]
2.Patients with serious complications(heart, liver, or kidney dysfunctions, hematopoietic disorders, malignant tumors, etc.) and other life-threatening diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath